Background: Ledderhose Disease, or plantar fibromatosis, is a fibroproliferative disorder affecting the plantar fascia with limited effective treatment options. Although hyaluronidase has a long history of clinical use, it has not been previously used for Ledderhose Disease. This study explores the use of combined hyaluronidase and triamcinolone acetonide enzymatic injections as a novel and promising technique for managing Ledderhose Disease. Methods: This paper investigates the use of combination therapy with hyaluronidase, triamcinolone acetonide, and lidocaine injections in three patients with Ledderhose Disease. Injection protocols, dosage, frequency, and patient outcomes are all discussed. Additionally, this study explores the underlying mechanisms of hyaluronidase action in Ledderhose Disease, shedding light on its potential to modulate fibrotic tissue and alleviate symptoms. Results: All three patients treated with a series of hyaluronidase, triamcinolone acetonide, and lidocaine anesthetic injections experienced either a significant reduction in or elimination of nodules and associated pain within 6 weeks after initial injection. Patients were asymptomatic at two years follow-up after injections. Conclusions: The combination of hyaluronidase and triamcinolone acetonide injections significantly decreased pain and softened fibromas faster than triamcinolone acetonide injection alone, as explored in previous studies. Large prospective studies are needed to further compare enzymatic injection therapies in the management of Ledderhose Disease.
Background: Total calcanectomy has been proposed as a definitive limb-salvage strategy in non-ambulatory patients with heel ulceration and calcaneal osteomyelitis, potentially facilitating primary wound closure and reducing complications associated with persistent bony prominence. Methods: A retrospective review of non-ambulatory patients undergoing partial or total calcanectomy for calcaneal osteomyelitis at a single limb salvage center between 2011 and 2021 was performed. Demographic, perioperative, and postoperative data were analyzed. Primary outcomes included wound complications, limb salvage, and subsequent proximal amputation. Statistical significance was defined as p ≤ 0.05. Results: Sixty-two patients underwent 63 calcanectomy procedures (48 partial, 15 total). Baseline demographic, vascular, laboratory, and microbiologic characteristics were comparable between groups. No statistically significant differences were observed in closure strategy, postoperative complications, length of stay, or limb salvage rates, although a non-significant trend toward higher below-knee amputation rates was observed following total calcanectomy. Conclusions: In medically complex, non-ambulatory patients, partial and total calcanectomy demonstrated similar rates across most measured outcomes, with a nonsignificant trend toward higher below-knee amputation after total calcanectomy that warrants further investigation with larger cohorts. These findings suggest that surgical decision-making should prioritize infection control and durable wound closure rather than preservation of calcaneal structure in this high-risk population.